XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency 
98% of Senior Living Leaders Agree Engagement Technology is Vital to Their Communities
In its third year, iN2L's annual survey of senior living leaders reveals engagement technology is more important than ever DENVER,...
StageZero Life Sciences Launches AVRT(TM) in the UK
Innovative program helps identify and address the early warning signs of cancer and chronic diseaseTORONTO, ON / ACCESSWIRE / March...
Wellteq Digital Health Inc. Launches North America Growth Division
wellteq has appointed Mr Andrew Hvzid as Head of Growth, North America.Based out of Toronto, Canada, Andrew Hvzid will be...
Trella Health Releases 2021 Post-Acute Care Industry Trend Report
Annual Publication Provides In-Depth Analysis on How Medicare Beneficiaries’ Utilization of Post-Acute Care Services Have Changed During the Pandemic ATLANTA--(BUSINESS...
PESI, Inc., Launches therapist.com, an Online Therapist Directory
Comprehensive new online resource connects licensed therapists with clients EAU CLAIRE, Wis., March 31, 2022 /PRNewswire/ -- The all-new therapist...
Business Update from Health Karma(TM) CEO, Travis Jackson
FORT LAUDERDALE, FL / ACCESSWIRE / March 31, 2022 / MediXall Group Inc. (OTCQB:MDXL), an innovative healthcare solutions provider, today...
Cosmos Holdings Launches Proprietary Sky Premium Life Brainlit Supplement for Brain Health
Designed to support and enhance brain functionCHICAGO, IL / ACCESSWIRE / March 31, 2022 / Cosmos Holdings, Inc. ("the Company")...
Gemina Labs Provides Technical Development Update for Initial Diagnostic Test and Reports Filing of New IP
VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to...
NLS Pharmaceutics Retains LifeSci Partners As Financial Advisor To Evaluate Strategic Partnering Initiatives
ZURICH, SWITZERLAND / ACCESSWIRE / March 31, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Goodbody Health Products Included on FSA Novel Foods Register
VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Goodbody Health Inc. (CSE:GDBY) (OTCQB:GDBYF) ("Goodbody Health" or the "Company") is...
Novamind Partner to Acquire Specialized Ibogaine Group in Brazil
Bienstar Plans To Build LATAM's First Network of Integrative Mental Health ClinicsTORONTO, ON / ACCESSWIRE / March 31, 2022 /...
South Rampart Pharma Appoints Robert Dickey, MBA, as Chief Financial Officer
Mr. Dickey brings over 25 years of experience as a CFO and COO in private, public, and revenue stage companies...
Jaguar Health Enters Exclusive Crofelemer Distribution and License Agreement with Quadri Pharmaceuticals Store for Multiple Target Indications in Middle East Markets
Agreement grants Quadri Pharmaceuticals Store exclusive promotional, commercialization, and distribution rights in Bahrain, Kuwait, Qatar, Saudi Arabia, the United Arab...
Assertio Holdings, Inc. Partners with BlinkRx to Support Healthcare Providers and Patients Utilizing Otrexup® (methotrexate) with a Unique Patient Access Solution
Collaboration Eases Patient Access to TherapyLAKE FOREST, Ill., March 31, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio”) (NASDAQ: ASRT)...
Philips adds to its cardiology suite of solutions at ACC 2022 with innovations to help improve patient outcomes, experiences, and care pathway effectiveness
Philips Ambient Experience and FlexVision display Philips Ultrasound Workspace March 31, 2022 Innovations designed to seamlessly work together, strengthen clinical...
Cell and Gene Therapies Poised to Disrupt Health Care Status Quo With Wave of New Treatments
Regenerative medicine takes aim at cancer and a wide range of other prevalent and rare diseasesWashington, DC, March 31, 2022...
Mapi Pharma to Present Posters on GA Depot for Treating Relapsing Forms of Multiple Sclerosis (MS) and Primary Progressive Forms of Multiple Sclerosis at the American Academy of Neurology (AAN) 2022 Annual Meeting
NESS ZIONA, Israel, March 31, 2022 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company...
Nancy Cocozza Joins Privia Health’s Board of Directors
ARLINGTON, Va., March 31, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced the addition of Nancy...
Sorrento Reports FDA Clearance for the Commencement of a Phase 2/3 Study for Abivertinib in Treatment of Hospitalized Patients With Severe Pneumonia Due to COVID-19
Abivertinib is a novel oral small molecule tyrosine kinase inhibitor that selectively targets both mutant forms of the epidermal growth...
HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in Treatment-Resistant Depression (TRD), suggesting antidepressant efficacy and showing Placebo-Level Dissociative Side Effects in Phase 2 oral prolonged-release Ketamine (KET01) Study
Phase 2 Proof-of-Concept study in TRD patients resistant to standard antidepressants suggests positive trend in efficacy.Potential first-in-class oral prolonged-release formulation...